-
The World's First Genetically Modified Spider Could Change The Future Of Military Tech
Tuesday, May 27, 2025 - 5:58am | 424Scientists backed by the U.S. Navy have created the world's first genetically modified spider. This achievement could pave the way to a new category of high-performance materials with major implications for defense, aerospace, and medicine. What Happened: A team at the University of Bayreuth in...
-
Bill Gates Gets Excited About Future Of Tech That Has 'Revolutionized Health' Over Past Decade
Monday, February 6, 2023 - 11:17pm | 522Microsoft co-founder Bill Gates said on Twitter that the gene-editing technology, CRISPR or clustered regularly interspaced short palindromic repeats, has “revolutionized health over the past decade.” What Happened: Gates said Monday that he was “excited to see” how CRISPR...
-
Could A Hypoallergenic Cat Be Coming Soon?
Tuesday, March 29, 2022 - 5:14pm | 466If science has its way, your cat allergy won't be an excuse to skip Thanksgiving at your grandmother's house, where her five cats also reside. Hypoallergenic cats could be making a debut sooner rather than later due to the magic of CRISPR gene-editing technology. While fur and dander, in...
-
Qiagen Launches CRISPR-Specific Products For Gene-Editing Experiments
Tuesday, June 22, 2021 - 6:45am | 154Qiagen NV (NYSE: QGEN) has launched dedicated solutions specific to CRISPR technology used for editing genomes and modifying gene function. QiaPrep&Amp CRISPR Kit and Q-Primer Solutions expand Qiagen portfolio for CRISPR applications. The solutions allow researchers to analyze...
-
AbbVie, Caribou Biosciences Ink Licensing Agreement For (CAR)-T Cell Therapeutics
Wednesday, February 10, 2021 - 11:04am | 245AbbVie Inc (NYSE: ABBV) and Caribou Biosciences have entered into a multi-year collaboration and license agreement to research and develop chimeric antigen receptor (CAR)-T cell therapeutics. AbbVie will utilize Caribou's Cas12a CRISPR hybrid RNA-DNA genome editing and cell...
-
IPO Outlook: Do 4 Biotechs Mean Maybe The IPO Market Is Back?
Tuesday, May 3, 2016 - 12:10pm | 4632016’s slow start for Initial Public Offerings (IPO) could be over, as four biotechs follow in the wake of several successful IPOs, most notably, BATS Global Markets, Inc. (BATS: BATS) and American Renal Associates Holdings Inc (NYSE: ARA). These stocks are up 25 and 26 percent, respectively...